COMMUNIQUÉS West-GlobeNewswire

Auris Medical Reports Third Quarter 2017 Financial Results and Provides Business Update

28/11/2017 - 12:40

HEALOS trial with AM-111 did not meet the primary efficacy endpoint, but showed statistically and clinically significant effect in profound acute hearing loss subpopulation Phase 3 results from Keyzilen ® TACTT3 trial [...]

Auris Medical Reports Top-Line Results from Phase 3 Trial of AM-111 in Sudden Deafness

28/11/2017 - 12:40

HEALOS trial did not meet primary efficacy endpoint in overall study population Clinically and statistically significant improvement in subpopulation of patients with profound acute hearing loss Conference call [...]

Cytovance Biologics, Inc. announces Bexion Pharmaceuticals Inc. has chosen Cytovance to manufacture the protein component and active ingredient of Bexion’s first clinical compound, BXQ-350

28/11/2017 - 11:00

OKLAHOMA CITY, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cytovance Biologics, Inc. (Cytovance), a leading full-service contract development and manufacturer of mammalian and microbial biologics, today announced that it has been [...]

US Patent Office Acknowledges Provisional Patent Application for Use of Specific Cannabis Strain to Enhance Opioid Analgesia Filed by Veritas’ Research Arm Cannevert

28/11/2017 - 09:05

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Veritas Pharma Inc. (CSE:VRT) (OTC:VRTHF) (Frankfurt: 2VP ), (“Veritas” or the “Company”) announces its research arm, Cannevert Therapeutics Ltd. (“CTL”) [...]

Cannabis Wheaton Income Corp. Announces Proposed Shares for Debt Settlement

28/11/2017 - 06:01

VANCOUVER, British Columbia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- Cannabis Wheaton Income Corp. (d/b/a Wheaton Income) (TSX.V:CBW) (" Wheaton Income " or the " Company ") has entered into settlement agreements (the " [...]

Prima BioMed Becomes Immutep

28/11/2017 - 01:12

SYDNEY, Australia, Nov. 28, 2017 (GLOBE NEWSWIRE) -- We refer to shareholder approval granted at the Company’s Annual General Meeting held on 17 November 2017 to change the name of the Company from ‘Prima BioMed Ltd’ to [...]

REVA to Present at 29th Annual Piper Jaffray Healthcare Conference

28/11/2017 - 00:37

SAN DIEGO, Nov. 27, 2017 (GLOBE NEWSWIRE) -- REVA Medical, Inc. (ASX:RVA) (“REVA” or the “Company”) is pleased to announce that its Chief Executive Officer, Ms. Reggie Groves, is scheduled to present at the 29th Annual [...]

Accelerate Diagnostics Joins Sepsis Alliance in Global #GivingTuesday Movement to Raise Awareness of Sepsis as Medical Emergency

28/11/2017 - 00:27

TUCSON, Ariz., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Accelerate Diagnostics, Inc. has teamed up with Sepsis Alliance for #GivingTuesday, November 28 th , a global day of giving that harnesses the collective power of [...]

AIT Therapeutics Announces Positive Preliminary Data for the Primary Endpoint of Safety in Its NO-NTM Abscessus Phase 2 Clinical Trial in Nontuberculous Mycobacteria (NTM) Patients

27/11/2017 - 22:56

No Serious Adverse Events Related to Treatment with Nitric Oxide Reported Compelling Preliminary Data on Key Secondary Endpoint of 6-Minute Walk NEW YORK, Nov. 27, 2017 (GLOBE NEWSWIRE) -- AIT Therapeutics Inc. (OTC: [...]

Aeterna Zentaris’ Marketing Authorization Application for Macrilen™ (macimorelin) for Evaluation of Adult Growth Hormone Deficiency Accepted by European Medicines Agency

27/11/2017 - 22:41

CHARLESTON, S.C., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS ) (TSX: AEZS ) announced that the Marketing Authorization Application (“MAA”) for the use of Macrilen™ (macimorelin) for the [...]

Radius Health Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

27/11/2017 - 22:35

WALTHAM, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. (“Radius” or the “Company”) (Nasdaq: RDUS ) today announced that its Board of Directors granted Joseph Kelly, in connection with his appointment as [...]

athenahealth Appoints Marc Levine as Chief Financial Officer and Treasurer

27/11/2017 - 22:30

WATERTOWN, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- athenahealth, Inc. (NASDAQ: ATHN ) a leading provider of network-enabled services for hospital and ambulatory clients nationwide, today announced that Marc A. Levine [...]

Otonomy Announces Plan to Focus Resources on Development Programs

27/11/2017 - 22:30

Company to focus resources on completing OTIVIDEX™ clinical development to support U.S. regulatory approval for Ménière’s disease, and advancing multiple other programs addressing hearing loss and tinnitus Discontinuing [...]

Sucampo Pharmaceuticals Announces its Participation at the Global Mizuho Investor Conference

27/11/2017 - 22:10

ROCKVILLE, Md., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Sucampo Pharmaceuticals, Inc. (Sucampo) (Nasdaq: SCMP ), a global biopharmaceutical company, today announced that it will participate in investor meetings at the Global [...]

Radius Health Announces Commercial Leadership Changes with Appointment of Joseph Kelly as Senior Vice President of Sales and Marketing, and Promotion of Amanda Mott to Senior Vice President of Market Access

27/11/2017 - 22:05

WALTHAM, Mass., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius" or the "Company") (Nasdaq: RDUS ) today announced the appointment of Joseph Kelly as Senior Vice President of Sales and Marketing, and the [...]

Optinose Reports Third Quarter 2017 Financial Results and Recent Operating Highlights

27/11/2017 - 22:05

YARDLEY, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Optinose (NASDAQ: OPTN ), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today reported financial results for [...]

OncoMed Announces Chairman, President and Chief Executive Officer Paul J. Hastings to Resume Chairman Responsibilities

27/11/2017 - 22:05

REDWOOD CITY, Calif., Nov. 27, 2017 (GLOBE NEWSWIRE) -- OncoMed Pharmaceuticals, Inc. (NASDAQ: OMED ), a clinical-stage biopharmaceutical company focused on discovering and developing novel anti-cancer therapeutics, [...]

Dova Pharmaceuticals Announces FDA Acceptance of the Avatrombopag New Drug Application (NDA) with Priority Review

27/11/2017 - 22:05

DURHAM, N.C., Nov. 27, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ: DOVA ) today announced the New Drug Application (NDA) for avatrombopag has been accepted for filing and has been granted Priority [...]

Telcare, a Division of BioTelemetry, Inc., Announces Collaboration with Onduo in Diabetes Management Program

27/11/2017 - 22:05

MALVERN, Pa., Nov. 27, 2017 (GLOBE NEWSWIRE) -- (NASDAQ: BEAT ) – Telcare, the manufacturer of the world’s first FDA-cleared cellular-enabled blood glucose monitor, has entered into a strategic collaboration with Onduo [...]